Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

The Conventional Therapy from Brazilian Type 1 Diabetes Study Group (CT)

JP Jaquellyne G. Penaforte-Saboia
RJ Renan M. Montenegro, Jr.
CC Carlos E. Couri
LB Livia A. Batista
AM Ana Paula D. R. Montenegro
VF Virginia O. Fernandes
HA Hussain Akhtar
CN Carlos A. Negrato
KM Kelen Cristina Ribeiro Malmegrim
DM Daniela Aparecida Moraes
JD Juliana B. E. Dias
BS Belinda P. Simões
MG Marilia Brito Gomes
MO Maria Carolina Oliveira
ask Ask a question
Favorite

The BrazDiab1 study group performed a multicenter retrospective, cross-sectional study on individuals with T1DM between December 2008 and December 2010, in 28 public clinics from the secondary and tertiary level of health care, from 20 cities (population > 100,000) from all the five Brazilian geographical regions (North, Northeast, Southeast, South and Midwest). All patients received health care from the National Brazilian Health Care System (NBHCS), and were regularly treated by an endocrinologist. All data were obtained from a single examination performed by trained medical professionals.

Details of BrazDiab1 have been published elsewhere (14). Briefly, participants were interviewed and demographic data were collected through a questionnaire. Furthermore, the following variables were assessed through an interview during a clinical visit and the patient’s medical records review.

Copyright and License information:  ©2017 Penaforte-Saboia, Montenegro, Couri, Batista, Montenegro, Fernandes, Akhtar, Negrato, Malmegrim, Moraes, Dias, Simões, Gomes and Oliveira.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A